![Abuse of a dominant position, denigration and misleading speech: disinformation sanctioned (Update Distribution / Competition by Christophe Héry and Claire Burlin, sept. 2020) Abuse of a dominant position, denigration and misleading speech: disinformation sanctioned (Update Distribution / Competition by Christophe Héry and Claire Burlin, sept. 2020)](medias/org-1549/shared/chess-3801531_1280-5f77411b49376.jpg)
Abuse of a dominant position, denigration and misleading speech: disinformation sanctioned (Update Distribution / Competition by Christophe Héry and Claire Burlin, sept. 2020)
Pubblicato il :
02/10/2020
02
octobre
oct.
10
2020
Disinformation carried out by one or more company(ies) can take many forms, targeting consumers, customers, influencers or public authorities, and targeting the image of competitors or their products or services. Depending on the case, it can be sanctioned on the basis of competition law, press freedom law or unfair competition law.
On September 9, 2020, the French Competition Authority (“Autorité de la concurrence” / AdlC) recalled, in a specific case, that denigration or disinformation could constitute an abuse of a dominant position by condemning Novartis, Roche and Genentech to the payment of a fine of 444 million euros. (See AdlC decision 20-D-11 here).
In a nutshell, AdlC found that the three laboratories attempted to curb the use of Avastin (produced by Genentech) as part of the treatment of age-related macular degeneration (AMD) because this product, which was initially an anticancer drug, has proved to be an effective and much cheaper alternative to Lucentis, also produced and marketed by these laboratories. Thus, curbing the use of Avastin in favor of Lucentis allowed them to maintain an artificially high price of this drug on the AMD market.
AdlC first retained that Novartis, Roche and Genentech formed a collective entity for the purposes of marketing the two drugs (Lucentis and Avastin), holding a dominant position in the AMD treatment market given the existence of important and strategic structural links between the laboratories (in particular the license agreements between Genentech and Novartis, for the marketing of Lucentis, and Genentech and Roche, for the marketing of Avastin) and the existence of crossed capitalistic links.
Then, it identified practices of denigration and disinformation of this treatment with the medical world (especially Key Opinion Leaders) as well as alarmist and misleading speeches with the public authorities in order to block their initiatives aimed at securing its use without authorization of marketed for the treatment of AMD.
Finally, AdlC did not fail to point out, at the sanction stage, that these practices occurred in a context of public debate on the extremely high price of Lucentis and its impact on social finances, while the Avastin, significantly cheaper, was likely to be used.
If these practices have been implemented by three laboratories against a treatment produced and marketed by themselves, abuse of a dominant position can be more classically established when a laboratory in a dominant position denigrates the specialties or devices of a competitor. For example, in the "Plavix" case, the French Court of Cassation upheld the conviction of the Sanofi Aventis laboratory for having disseminated a broad and structured communication to healthcare professionals aimed at denigrating competing generic medicines. The similarities between the cases remain limited because the Sanofi Aventis laboratory was condemned even though the information relating to the differences between competing generics and the Plavix it marketed was correct (Cass. Com. December 18, 2014, n ° 2013 / 12370).
This decision is also an opportunity to recall that, more broadly, French law places limits on criticism of a competitor. Thus, the fact of criticizing a company (or its directors) by attributing to them specific facts (such as corruption, non-compliance with regulations, fraud, etc.) can only be sanctioned on the basis of the defamation provided for by the law of July 29, 1881 on press freedom, while the fact of criticizing a product or a service of a merchant can be sanctioned only on the basis of an action in unfair competition by denigration, even in the absence of a situation of direct and effective competition (Cass. Com. 26 September 2018, n ° 17 / 15.502; Cass. Com. 19 January 2019, n ° 17 / 18.350 ; Cass. Com. 13 March 2019, n° 18 / 11.046) (See our article here).
By Christophe Héry and Claire Burlin
{ PARTAGER_SUR }
{ TWEETER_CET_ARTICLE }
{ PARTAGER_SUR } LinkedIn
{ PARTAGER_SUR } Facebook
{ ENVOYER_PAR_EMAIL }
{ HISTORIQUE }
-
Une société en commandite par actions peut être absorbée par voie de fusion simplifiée
Pubblicato il : 28/10/2020 28 octobre oct. 10 2020Droit des sociétés / Fusions et acquisitionsPour l'Ansa, le texte autorisant la fusion simplifiée de sociétés anonymes, s...Fonte : www.efl.fr
-
Le Digital Services Act (DSA) au service d’une protection accrue des consommateurs face aux plateformes numériques
Pubblicato il : 15/10/2020 15 octobre oct. 10 2020Droit de la consommationPartant du constat que la directive e-commerce ne répond plus aux enjeux actu...Fonte : droit-des-affaires.efe.fr
-
Altaïr Avocats crea un Italian Desk // Altaïr Avocats crée un Italian desk
Pubblicato il : 14/10/2020 14 octobre oct. 10 2020Vie du CabinetAltaïr Avocats crea un Italian Desk dedicato alle aziende italiane che deside...
-
Une distribution frauduleuse de dividendes déclarée inopposable à un minoritaire
Pubblicato il : 13/10/2020 13 octobre oct. 10 2020Droit des sociétés / Droit des sociétés commerciales et professionnellesUn apport des actifs d’une SAS consenti sans avoir consulté un minoritaire n’...Fonte : www.efl.fr
-
Altaïr Avocats conseille le Groupe Médiaperf pour l’acquisition de Fidme
Pubblicato il : 12/10/2020 12 octobre oct. 10 2020DealsAltaïr Avocats a accompagné le Groupe Médiaperf à l’occasion de son acquisiti...
-
Webinaire Corporate (1ere partie) : « Bien préparer son acquisition »
Pubblicato il : 07/10/2020 07 octobre oct. 10 2020Publications et SéminairesRetour sur le webinaire "Bien préparer son acquisition" organisé par l’AFJE l...
-
Levée de fonds de 15 M€ de Newheat auprès de Triodos Bank et du Crédit Coopératif et de fonds régionaux spécialisés dans la transition énergétique, pour développer des centrales solaires thermiques
Pubblicato il : 06/10/2020 06 octobre oct. 10 2020DealsAltaïr Avocats a conseillé NEWHEAT dans le cadre d'une levée de fonds de 15 M...
-
Altaïr Avocats recherche un(e) stagiaire en Droit Economique (contrats / contentieux) pour 6 mois à compter de janvier 2021
Pubblicato il : 05/10/2020 05 octobre oct. 10 2020Vie du CabinetAltaïr Avocats est un cabinet d’avocats d’affaires français, fondé en 2019, q...
-
Abuse of a dominant position, denigration and misleading speech: disinformation sanctioned (Update Distribution / Competition by Christophe Héry and Claire Burlin, sept. 2020)
Pubblicato il : 02/10/2020 02 octobre oct. 10 2020Publications et SéminairesDisinformation carried out by one or more company(ies) can take many forms, t...